Potential Application of Nanoparticles as Antipathogens - Advanced Materials for Agriculture, Food and Environmental Safety - page 359

16. S.R. Kumar, and R. Vijaylakshmi, “Nanotechnology in dentistry”,
Indian J. Dent. Res. ,Vol. 17, No. 2, pp. 62-65, 2006. http://dx.doi.org/
10.4103/0970-9290.29890.
17. S.V. Kyriacou, W.J. Brownlow, and X.-H.N. Xu, “Using nanoparticle optics
assay for direct observation of the function of antimicrobial agents in single
live bacterial cells”, Biochemistry , Vol. 43, pp. 140-7, 2004.
18. R. Langer, “Biomaterials in drug delivery and tissue engineering: One labo-
ratory's experience”, Acc. Chem. Res. ,Vol. 33, pp. 94-101, 2000.
19. P. Li, J. Li, C. Wu, Q. Wu, J. Li, “Synergistic antibacterial ef ects of β -lactam
antibiotic combined with silver nanoparticles”, Nanotechnology , Vol. 16,
pp. 1912-1917, 2005.
20. Y. Liu, H. Miyoshi, and M. Nakamura, “Nanomedicine for drug delivery and
imaging: A promising avenue for cancer therapy and diagnosis using tar-
geted functional nanoparticles”, Int. J. Cancer , Vol. 120, pp. 2527-2537, 2007.
21. M.K. Rai, S.D. Deshmukh, A.P. Ingle, and A.K. Gade, “Silver nanoparticles:
h e powerful nanoweapon against multidrug-resistant bacteria”, J. Appl.
Microbiol. , ISSN: 1364-5072.
22. J.P. Mathuria, “Nanoparticles in tuberculosis diagnosis,treatment and pre-
vention: A hopefor the future”, Digest Journal Nanomaterials Biostructure ,
Vol.4, No.2, pp. 309-312, June 2009.
23. V. Wagner, A. Dullaart, A.K. Bock, A. Zweck, “h e emerging nanomedi-
cine landscape”, Nat. Biotechnol. , Vol. 24, No. 10, pp. 1211-1217, 2006.
doi:10.1038/nbt1006-1211. PMID 17033654.
24. R.H. Muller, and B.H.L. Bohm, “Nanosuspensions,” in: R.H. Muller, S. Benita,
B.H.L. Bohm, eds., “Emulsions and Nanosuspensions for the Formulation of
Poorly Soluble Drugs”, Stuttgart: Medpharm, pp. 149-174, 1998.
25. D.F. Emerich, and C.G. h anos, “Targeted nanoparticle-based drug delivery
and diagnosis”, J. Drug Target , Vol. 15, pp. 163-183, 2007.
26. R.O. Esenaliev, “Radiation and nanoparticles for enhancement of drug deliv-
ery in solid tumors”, PCT Int Appl 2000, WO 2000002590.
27. A.J. h ote, R.B. Gupta, “Formation of nanoparticles of a hydrophilic drug
using supercritical carbon dioxide and microencapsulation for sustained
release”, Nanomedicine: Nanotech. Biology Medicine , Vol. 1, pp. 85-90,
2005.
28. V.P. Torchilin, “Recent advances with liposomes as pharmaceutical carriers”,
Nat. Rev. Drug Discov. , Vol. 4, pp. 145-159, 2005.
29. O.C. Farokhzad, and R. Langer, “Nanomedicine: developing smarter thera-
peutic”, Adv. Drug Deliv. Rev. , Vol. 58, pp. 1456-1459, 2006.
30. R. Duncan, “Polymer conjugates as anticancer nanomedicines”, Nat. Rev.
Cancer , Vol. 6, pp. 688-701, 2006.
31. R. Jurgons, et al ., “Drug loaded magnetic nanoparticles for cancer therapy”,
J. Phys. Condens. Matter ,Vol. 18, pp. S2893-S2902, 2006.
32. J. Kreuter, ed., “Nanoparticles, in: Colloidal Drug Delivery Systems” , Marcel
Dekker: New York, pp 219-342, 1994.